Updates on HER2-Directed ADCs Across Solid Tumors - Episode 3
ADCs Targeting HER2+ Gynecologic Cancers
Vijayakrishna Gadi, MD, University of Illinois College of Medicine, Susana Campos, MD, MPH, Matthew D. Galsky, MD, Edward Garon, MD, Jonsson Comprehensive Cancer Center at UCLA, Aparna R. Parikh, MD Dr Campos discusses the potential for T-DXd in other gynecologic cancers and offers an overview of results from the DESTINY-PanTumor02 trial.
Video content above is prompted by the following:
- What is the potential for T-DXd in other gynecologic cancers?